554 related articles for article (PubMed ID: 15197743)
1. Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum.
Tebano MT; Pintor A; Frank C; Domenici MR; Martire A; Pepponi R; Potenza RL; Grieco R; Popoli P
J Neurosci Res; 2004 Jul; 77(1):100-7. PubMed ID: 15197743
[TBL] [Abstract][Full Text] [Related]
2. Adenosine A 2A receptor antagonists prevent the increase in striatal glutamate levels induced by glutamate uptake inhibitors.
Pintor A; Galluzzo M; Grieco R; Pèzzola A; Reggio R; Popoli P
J Neurochem; 2004 Apr; 89(1):152-6. PubMed ID: 15030399
[TBL] [Abstract][Full Text] [Related]
3. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of the A2A receptor agonist CGS21680 in the striatum of Huntington's disease versus wild-type mice.
Martire A; Calamandrei G; Felici F; Scattoni ML; Lastoria G; Domenici MR; Tebano MT; Popoli P
Neurosci Lett; 2007 Apr; 417(1):78-83. PubMed ID: 17331645
[TBL] [Abstract][Full Text] [Related]
5. Region-specific neuroprotective effect of ZM 241385 towards glutamate uptake inhibition in cultured neurons.
Pepponi R; Ferrante A; Ferretti R; Martire A; Popoli P
Eur J Pharmacol; 2009 Sep; 617(1-3):28-32. PubMed ID: 19619523
[TBL] [Abstract][Full Text] [Related]
6. Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum.
Popoli P; Pintor A; Domenici MR; Frank C; Tebano MT; Pèzzola A; Scarchilli L; Quarta D; Reggio R; Malchiodi-Albedi F; Falchi M; Massotti M
J Neurosci; 2002 Mar; 22(5):1967-75. PubMed ID: 11880527
[TBL] [Abstract][Full Text] [Related]
7. Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission.
Tozzi A; Tscherter A; Belcastro V; Tantucci M; Costa C; Picconi B; Centonze D; Calabresi P; Borsini F
Neuropharmacology; 2007 Nov; 53(6):783-9. PubMed ID: 17889039
[TBL] [Abstract][Full Text] [Related]
8. Behavioural and neurochemical characterization of the adenosine A2A receptor antagonist ST1535.
Galluzzo M; Pintor A; Pèzzola A; Grieco R; Borsini F; Popoli P
Eur J Pharmacol; 2008 Jan; 579(1-3):149-52. PubMed ID: 18036583
[TBL] [Abstract][Full Text] [Related]
9. Modulation of glutamate release and excitotoxicity by adenosine A2A receptors.
Popoli P; Frank C; Tebano MT; Potenza RL; Pintor A; Domenici MR; Nazzicone V; Pèzzola A; Reggio R
Neurology; 2003 Dec; 61(11 Suppl 6):S69-71. PubMed ID: 14663014
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
Nörenberg W; Wirkner K; Illes P
Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
[TBL] [Abstract][Full Text] [Related]
11. Adenosine A2A receptor-induced inhibition of NMDA and GABAA receptor-mediated synaptic currents in a subpopulation of rat striatal neurons.
Wirkner K; Gerevich Z; Krause T; Günther A; Köles L; Schneider D; Nörenberg W; Illes P
Neuropharmacology; 2004 Jun; 46(7):994-1007. PubMed ID: 15081796
[TBL] [Abstract][Full Text] [Related]
12. Effects of the adenosine A2A receptor antagonist SCH 58621 on cyclooxygenase-2 expression, glial activation, and brain-derived neurotrophic factor availability in a rat model of striatal neurodegeneration.
Minghetti L; Greco A; Potenza RL; Pezzola A; Blum D; Bantubungi K; Popoli P
J Neuropathol Exp Neurol; 2007 May; 66(5):363-71. PubMed ID: 17483693
[TBL] [Abstract][Full Text] [Related]
13. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes.
Brambilla R; Cottini L; Fumagalli M; Ceruti S; Abbracchio MP
Glia; 2003 Aug; 43(2):190-4. PubMed ID: 12838511
[TBL] [Abstract][Full Text] [Related]
14. Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner.
Gomes CA; Vaz SH; Ribeiro JA; Sebastião AM
Brain Res; 2006 Oct; 1113(1):129-36. PubMed ID: 16935271
[TBL] [Abstract][Full Text] [Related]
15. Remodeling of striatal NMDA receptors by chronic A(2A) receptor blockade in Huntington's disease mice.
Martire A; Ferrante A; Potenza RL; Armida M; Ferretti R; Pézzola A; Domenici MR; Popoli P
Neurobiol Dis; 2010 Jan; 37(1):99-105. PubMed ID: 19804830
[TBL] [Abstract][Full Text] [Related]
16. 3-Nitropropionic acid toxicity in hippocampus: protection through N-methyl-D-aspartate receptor antagonism.
Karanian DA; Baude AS; Brown QB; Parsons CG; Bahr BA
Hippocampus; 2006; 16(10):834-42. PubMed ID: 16897723
[TBL] [Abstract][Full Text] [Related]
17. Striatal plasticity at the network level. Focus on adenosine A2A and D2 interactions in models of Parkinson's Disease.
Tanganelli S; Sandager Nielsen K; Ferraro L; Antonelli T; Kehr J; Franco R; Ferré S; Agnati LF; Fuxe K; Scheel-Krüger J
Parkinsonism Relat Disord; 2004 Jul; 10(5):273-80. PubMed ID: 15196505
[TBL] [Abstract][Full Text] [Related]
18. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution.
Abulrob A; Tauskela JS; Mealing G; Brunette E; Faid K; Stanimirovic D
J Neurochem; 2005 Mar; 92(6):1477-86. PubMed ID: 15748165
[TBL] [Abstract][Full Text] [Related]
19. Adenosine receptors--the role in modulation of dopamine and glutamate release in the rat striatum.
Gołembiowska K; Zylewska A
Pol J Pharmacol; 1997; 49(5):317-22. PubMed ID: 9566030
[TBL] [Abstract][Full Text] [Related]
20. Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition.
Lopes LV; Cunha RA; Kull B; Fredholm BB; Ribeiro JA
Neuroscience; 2002; 112(2):319-29. PubMed ID: 12044450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
